IQ4I Research & Consultancy published a new report on “Dialysis Devices Global Market – Forecast To 2022”

Dialysis is the treatment method for the patients with end-stage renal disease (ESRD) or kidney injury until they get kidney transplant and, for lifetime in case of transplant kidney rejection and lack of kidney donors. Dialysis often involves diverting blood to a machine that performs the major function of the kidneys with the help of a dialyzer by removing wastes and excess fluid from the blood and then returns the cleansed blood to the patient’s body. As estimated by IQ4I Research, Dialysis devices global market is valued at $ million in 2015 and expected to grow at a moderate rate to reach $19,289 million by 2022.

The factors driving the growth of this market are increasing number of ESRD patients & substantial healthcare expenditure on the treatment of ESRD, growing number of patients suffering from diabetes and hypertension, rise in aging population, rising adoption of dialysis procedures over renal transplants, technological advancements and new product launches are driving the market growth.

Risk and complications associated with dialysis such as low blood pressure, anaemia and infection, product recalls, reimbursement cuts for dialysis in North America and limited reimbursements for dialysis in developing countries, stringent regulatory policies for the approval of new dialysis devices and global efforts to cost containments are hampering the market growth.

The dialysis devices global market by type is mainly segmented into hemodialysis and peritoneal dialysis. Hemodialysis consists of hemodialysis products such as machines and consumables like dialyzers, concentrates, access products, bloodlines and hemodialysis modalities whereas the peritoneal dialysis consists of products such as machines, dialysate, transfer sets and modalities. Hemodialysis segment holds the largest share and peritoneal dialysis segment expected to grow at highest CAGR from 2015 to 2022.

The dialysis devices market by end-users is mainly segmented into In-Center dialysis and Home dialysis. The In-Centre dialysis further segmented into Hospital dialysis and Dialysis Centers whereas the Home dialysis is further segmented into Peritoneal Dialysis and Home Hemodialysis. In-Center dialysis holds the largest share 2015 and Home dialysis segment is expected to grow at a highest CAGR from 2015 to 2022.

The dialysis devices global market by geography is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). Europe region commanded the largest market share in 2015 due to increasing incidence of end-stage renal disease (ESRD), increasing hemodialysis facilities, increasing aging populations and increasing awareness of dialysis therapies. However, Asia-Pacific region is expected to grow at a highest CAGR and expected to be largest market by 2022 due to high number of ESRD patients, increasing healthcare expenditure, increasing awareness of healthcare, and refining healthcare infrastructure in the emerging countries, such as India and China.

The major players in dialysis devices global market include are Asahi Kasei Corp. (Japan), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), JMS Co. Ltd. (Japan), Kawasumi Laboratories (Japan), Nikkiso Co., Ltd. (Japan), Nipro Corporation (Japan), NxStage Medical Inc. (U.S.) and Toray Industries Inc. (Japan).

IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd. is a global strategy, consulting and a market research firm. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified consultants and market researchers, committed to help clients make strategic decisions by providing relevant and firmly reliable Intelligence support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports.

No- 11, Industrial Suburb,
1st Stage, West of Chord Road,
Rajaji Nagar, Bangalore - 560010

This release was published on openPR.